NIH-funded research R01 grant

Measuring and distinguishing sugar patterns on proteins

Official title: Quantitative Characterization of Glycopeptide Isomers

Funded at Texas Tech University · NIH-11299509 · Data updated 2026-11-12

This project develops lab methods to measure subtle sugar decorations on proteins that could help researchers studying Alzheimer’s disease, COVID-19, and other conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Tech University
NIH-funded
Lab location1 site (Lubbock, United States)
Project startFebruary 1, 2019
Project endJanuary 31, 2027
Funding year2026
Award (this year)$328,960
NIH project number5R01GM130091-08
Project IDNIH-11299509 on NIH RePORTER

Who could benefit from this research

Could help

People with Alzheimer’s disease or others willing to donate blood, cerebrospinal fluid, or tissue samples for biomarker research would be appropriate contributors to follow-up studies.

Less likely to help

This project does not offer direct therapy, so patients seeking immediate treatment benefit or those not able to provide samples are unlikely to benefit directly.

What this research studies

If you or a loved one has Alzheimer’s disease, researchers in this project are improving lab tools that read tiny sugar attachments on proteins linked to disease. They will combine special chromatography, isotope labeling, targeted mass spectrometry, chemical tagging, and better software to separate, count, and identify nearly identical sugar-protein forms. These lab advances aim to make detection faster and more reliable so disease-related changes are clearer. While this work is mainly in the lab, the improved measurements could be used on blood, spinal fluid, or tissue samples from patients.

Why it matters

Potential benefit: If successful, the new methods could make it easier to detect disease-linked sugar changes and speed biomarker discovery for diagnosis or treatment development.

How similar studies have gone: Previous glycoproteomics studies have found disease-associated sugar changes, but reliably distinguishing isomeric glycopeptides is still a newer and technically challenging goal.

Where this research is happening

  • Texas Tech University
    Lubbock, United States
    Active

Researchers

  • Principal investigator: Mechref, Yehia — Texas Tech University
  • Study coordinator: Mechref, Yehia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.